Functional interactions and signaling properties of mammalian DNA mismatch repair proteins

Cell Death and Differentiation

Volumn 8, Issue 11, 2001, Pages 1076-1092

  Bellacosa, A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Apoptosis; DNA damage; Mismatch repair; Signal transduction

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; CISPLATIN; DNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; BASE MISPAIRING; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CELL DEATH; COLORECTAL CANCER; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; EXCISION REPAIR; FAMILIAL CANCER; GENE DELETION; GENE FUNCTION; GENE INACTIVATION; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MAMMAL; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BASE PAIR MISMATCH; DNA DAMAGE; DNA LIGASES; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; MAMMALS; MODELS, MOLECULAR; NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; SIGNAL TRANSDUCTION;

EID: 0035161816     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400948     Document Type: Review

References (120)

1. Identification of mismatch repair genes and their role in the development of cancer
2. Mismatch repair in replication fidelity, genetic recombination, and cancer biology
3. Replication errors: Cha(lle)nging the genome
4. Eukaryotic DNA mismatch repair
5. Lessons from hereditary colorectal cancer
6. Cancer cells exhibit a mutator phenotype
7. Genetic susceptibility to non-polyposis colorectal cancer
8. Cancer of the microsatellite mutator phenotype
9. In vivo requirement for RecJ, ExoVII, Exol, and ExoX in methyl-directed mismatch repair
10. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells
11. hMutSβ, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA
12. hMSH5: A human MutS homologue that forms a novel heterodimer with hMSH4 and is expressed during spermatogenesis
13. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs
14. Identification of hMutLbeta, a heterodimer of hMLH1 and hPMS1
15. MLH3: A DNA mismatch repair gene associated with mammalian microsatellite instability
16. Repair of large insertion/deletion heterologies in human nuclear extracts is directed by a 5′ single-strand break and is independent of the mismatch repair system
17. Functional overlap in mismatch repair by human MSH3 and MSH6
18. Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA
19. Altering the conserved nucleotide binding motif in the Salmonella typhimurium MutS mismatch repair protein affects both its ATPase and mismatch binding activities
20. MutS mediates heteroduplex loop formation by a translocation mechanism
21. Crystal structure and ATPase activity of MutL: Implications for DNA repair and mutagenesis
22. MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast
23. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair
24. Mammalian DNA mismatch repair
25. Functional specificity of MutL homologs in yeast: Evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction
26. The crystal structure of DNA mismatch repair protein MutS binding to a G T mismatch
27. Guarding against mutation
28. Composite active site of an ABC ATPase: MutS uses ATP to verify mismatch recognition and authorize DNA repair
29. hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA
30. DNA mismatch repair: The hands of a genome guardian
31. Transformation of MutL by ATP binding and hydrolysis: A switch in DNA mismatch repair
32. Structural basis for MutH activation in E.coli mismatch repair and relationship of MutH to restriction endonucleases
33. Mismatch repair, molecular switches, and signal transduction
34. The human mismatch recognition complex hMSH2-hMSH6 functions as a novel molecular switch
35. Signaling mismatch repair in cancer
36. Nucleotide-promoted release of hMutSα from heteroduplex DNA is consistent with an ATP-dependent translocation mechanism
37. ATP hydrolysis-dependent formation of a dynamic ternary nucleoprotein complex with MutS and MutL
38. ATP-dependent assembly of a ternary complex consisting of a DNA mismatch and the yeast MSH2-MSH6 and MLH1-PMS1 protein complexes
39. Interaction of MutS and MutL at a DNA mismatch
40. Mismatch repair: The praying hands of fidelity
41. DNA mismatch repair: MutS structures bound to mismatches
42. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis
43. A mutation of the yeast gene encoding PCNA destabilizes both microsatellite and minisatellite DNA sequences
44. Functional interaction of PCNA with MSH2-MSH6 and MSH2-MSH3 complexes
45. Proliferating cell nuclear antigen and Msh2p-Msh6p interact to form an active mispair recognition complex
46. hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci
47. MSH-MLH complexes formed at a DNA mismatch are disrupted by the PCNA sliding clamp
48. Human exonuclease I interacts with the mismatch repair protein hMSH2
49. Germline mutations of exo1 gene in patients with hereditary nonpolyposis colorectal cancer (hnpcc) and atypical hnpcc forms
50. Strand-specific mismatch repair in mammalian cells
51. Molecular genetics of hereditary nonpolyposis colorectal cancer
52. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
53. Diagnostic microsatellite instability: Definition and correlation with mismatch repair protein expression
54. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer
55. Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: Examination of mutations found in hereditary nonpolyposis colorectal cancer
56. Quality control by DNA repair
57. Mechanisms of DNA excision repair
58. Transcription-coupled repair and human disease
59. Transcription-coupled repair of DNA damage: Unanticipated players, unexpected complexities
60. Transcription-coupled repair deficiency and mutations in human mismatch repair genes
61. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair
62. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells
63. Physical interaction between components of DNA mismatch repair and nucleotide excision repair
64. Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct
65. BRCA1 required for transcription-coupled repair of oxidative DNA damage
66. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair
67. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
68. Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1
69. MED1, a novel human methyl-CpG-binding endonuclease, interacts with the DNA mismatch repair protein MLH1
70. Chemistry of glycosylases and endonucleases involved in base-excision repair
71. General introduction to DNA base excision repair
72. Base excision repair of DNA in mammalian cells
73. DNA damages processed by base excision repair: Biological consequences
74. Enzymology of the repair of etheno adducts in mammalian cells and in Escherichia coli
75. Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repair
76. Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase
77. Role of MED1 (MBD4) Gene in DNA repair and human cancer
78. Biphasic Kinetics of the Human DNA Repair Protein MED1 (MBD4), a Mismatch-Specific DNA N-Glycosylase
79. Human DNA mismatch repair in vitro operates independently of methylation status at CpG sites
80. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites
81. Investigation of the substrate spectrum of the human mismatch-specific DNA N-glycosylase MED1 (MBD4): Fundamental role of the catalytic domain
82. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA
83. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency
84. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability
85. 4-ethenocytosine, a highly mutagenic adduct, is a primary substrate for Escherichia coli double-stranded uracil-DNA glycosylase and human mismatch-specific thymine-DNA glycosylase
86. Very short patch repair: Reducing the cost of cytosine methylation
87. Mechanism and control of interspecies recombination in Escherichia coli. I. Mismatch repair, methylation, recombination and replication functions
88. Roles for mismatch repair factors in regulating genetic recombination
89. Role of Saccharomyces cerevisiae Msh2 and Msh3 repair proteins in double-strand break-induced recombination
90. SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination
91. Defects in mismatch repair promote telomerase-independent proliferation
92. The Bloom's syndrome protein (BLM) interacts with MLH1 but is not required for DNA mismatch repair
93. Increased somatic recombination in methylation tolerant human cells with defective DNA mismatch repair
94. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer
95. Meiotic chromosomes: It takes two to tango
96. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis
97. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over
98. Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis
99. MutS homolog 4 localization to meiotic chromosomes is required for chromosome pairing during meiosis in male and female mice
100. Multiple functions of MutS- and MutL-related heterocomplexes
101. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage
102. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair
103. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint
104. The human MLH1 cDNA complements DNA mismatch repair defects in Mlh1-deficient mouse embryonic fibroblasts
105. Mismatch repair and cancer
106. Apoptosis induced by overexpression of hMSH2 or hMLH1
107. p53, the cellular gatekeeper for growth and division
108. hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
109. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
110. Disruption of p53 in human cancer cells alters the responses to therapeutic agents
111. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53
112. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
113. The role of DNA mismatch repair in drug resistance
114. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents
115. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin
116. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
117. Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathways
118. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine
119. Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis
120. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection